Ehrlich Christopher B has filed 22 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 4530997 shares of CERO THERAPEUTICS HOLDINGS, INC. ($CERO) on January 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Chairman and CEO | A | Stock Option (Right to Buy) | 4530997 | $0.00 | 4,530,997.0000 | 1,264,884 | 9999.99% | 100.00% |
| May 30, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Chairman and CEO | A | Stock Option (Right to Buy) | 61843 | $0.00 | 61,842.0000 | 3,427,616 | 0.00% | 1.80% |
| March 4, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Chairman and CEO | A | Stock Option (Right to Buy) | 119486 | $0.00 | 119,486.0000 | 579,432 | 9999.99% | 20.62% |
| Feb. 24, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Chairman and CEO | A | Stock Option (Right to Buy) | 1275000 | $0.00 | 2,550,000.0000 | 579,432 | 100.00% | 100.00% |
| Dec. 2, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Chairman and CEO | A | Stock Option (Right to Buy) | 1275000 | $0.00 | 1,275,000.0000 | 24,838 | 9999.99% | 100.00% |
| Sept. 25, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Interim Chairman and CEO | M | Common Stock | 5312983 | $0.00 | 5,795,408.0000 | 8,099 | 1101.31% | 100.00% |
| Sept. 30, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Interim Chairman and CEO | D | Stock Option (Right to Buy) | 572182 | $0.00 | 0.0000 | 8,099 | 100.00% | 100.00% |
| Sept. 25, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Interim Chairman and CEO | M | Series A Convertible Preferred Stock | 275 | $1000.00 | 0.0000 | 8,099 | 100.00% | 3.40% |
| June 13, 2024 | eFFECTOR Therapeutics, Inc. | $EFTR | Ehrlich Christopher B | Not found | A | Stock Option (Right to Buy) | 800 | $0.00 | 800.0000 | 4,704,409 | 9999.99% | 0.02% |
| March 25, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Director | A | Stock Option (Right to Buy) | 572182 | $0.00 | 572,182.0000 | 292 | 9999.99% | 100.00% |
| Feb. 19, 2024 | eFFECTOR Therapeutics, Inc. | $EFTR | Ehrlich Christopher B | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 2,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Director | A | Series A Convertible Preferred Stock | 100 | $1000.00 | 100.0000 | 292 | 9999.99% | 34.25% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Director | J | Series A Convertible Preferred Stock | 175 | $1000.00 | 275.0000 | 292 | 175.00% | 59.93% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Director | J | Warrants | 349998 | $0.00 | 5,000.0000 | 292 | 98.59% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Director | J | Warrants | 5000 | $0.00 | 5,000.0000 | 292 | 9999.99% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Director | M | Series A Convertible Preferred Stock | 1555 | $1000.00 | 1,830.0000 | 292 | 565.45% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Director | J | Common Stock | 1125000 | $0.00 | 4,653,671.0000 | 292 | 19.47% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Director | J | Common Stock | 4171246 | $0.00 | 1,482,425.0000 | 292 | 73.78% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Director | J | Common Stock | 3600 | $0.00 | 1,482,425.0000 | 292 | 0.24% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Director | M | Convertible Promissory Note | 0 | $0.00 | 0.0000 | 292 | 0.00% | 0.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Director | J | Common Stock | 478825 | $0.00 | 1,482,425.0000 | 292 | 47.71% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Ehrlich Christopher B | Director | J | Series A Convertible Preferred Stock | 1555 | $1000.00 | 275.0000 | 292 | 84.97% | 100.00% |